Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
169.5 USD | -0.96% | -1.49% | +9.41% |
04:27pm | AbbVie: acquisition of Celsius for $250 million | CF |
03:59pm | AbbVie Buys Celsius Therapeutics for $250 Million | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.41% | 302B | |
+54.77% | 811B | |
+43.62% | 640B | |
-6.53% | 353B | |
+18.54% | 333B | |
+16.81% | 246B | |
+2.54% | 225B | |
+12.71% | 218B | |
+9.25% | 168B | |
-5.44% | 155B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Secures Rights to OSE Immunotherapeutics' Drug Candidate